TAX 3503, A prospective registry -A Randomized, Open label, Muiticenter, Phase III, 2 Arm Study of Androgen Deprivation with Leuprilode +/- Docetaxel for Clinically Asymptomatic Prostate Cancer Subjects with a Rising PSA Following D. local therapy